Weight Loss

---

Initial Consult -With Labs

- CBC

- CMP

- Thyroid Panel

- Lipid Panel 

- Hemoglobin A1C

- Insulin Fasting

SKINNY SHOT

2 Options

This medication falls into the GLP-1 agonist class of drugs.  It stimulates the release of insulin, suppression of glucagon, slower gastric emptying, and increased satiety (fullness).

2nd Skinny shot with 2  mechanisms

Combined GLP-1 And GLP

Both of those hormones are released when we eat food.   The appetite center in the brain also recognizes this and turns on the "sense of fullness" sensation so we stop eating. 

1. Regulate Appetite: LDN may influence appetite regulation by controlling food intake and reward mechanisms and could potentially reduce cravings and caloric intake.
2. Regulate Metabolism:  may have metabolic effects, such as increasing resting metabolic rate and enhancing energy expenditure and contributing to weight loss over time.
3. Impact Inflammation: Chronic inflammation is implicated in obesity and metabolic dysfunction. LDN has been shown to modulate inflammatory pathways.

• Phentermine  
• Phentermine/Topiramate
• Bupropion/Naltrexone
• Evekeo